ComKardia, Inc.

Biotechnology company · Newton, Massachusetts, United States

ComKardia, Inc. is a biotechnology company headquartered in Newton, Massachusetts, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $250,000 sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

ComKardia at a glance

Typebiotechnology company

HeadquartersNewton, Massachusetts, United States

Earliest incorporation on record2021

SEC CIK1932266

What does ComKardia do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $250,000 sold (2022).

Frequently asked questions about ComKardia

Where is ComKardia headquartered?

ComKardia, Inc. is headquartered in Newton, Massachusetts, United States.

What does ComKardia do?

ComKardia, Inc. is a biotechnology company.

When was ComKardia founded?

The earliest incorporation on record for ComKardia, Inc. is in 2021, according to public company registers.

Similar companies

Lumicell, Inc.Newton, Massachusetts, United States
Acumen Pharmaceuticals, Inc.Newton, Massachusetts, United States
Courage Therapeutics, Inc.Newton, Massachusetts, United States
Extend Biosciences IncNewton, Massachusetts, United States
Normatec Industries, LPNewton, Massachusetts, United States
TheraNano LLCNewton, Massachusetts, United States
Auron Therapeutics, Inc.Newton, Massachusetts, United States
Diceros Therapeutics, Inc.Newton, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences